Neothetics Company Profile (NASDAQ:NEOT)

About Neothetics

Neothetics logoNeothetics, Inc. is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. It has completed Phase II development of LIPO-202. LIPO-202 is administered in a subcutaneous injection procedure that activates a natural metabolic process to shrink fat cells, without killing them, resulting in localized fat reduction, measurable results within four weeks and minimal risk with no downtime. The Company is developing a product candidate, LIPO-102, an injectable form of a combination of salmeterol xinafoate and fluticasone propionate. LIPO-102 is indicated for the treatment of the orphan indication of symptomatic exophthalmos, or protrusion of the eye from the orbit, associated with thyroid-related eye disease caused by the expansion of fat and muscle behind the eye.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NEOT
  • CUSIP:
Key Metrics:
  • Previous Close: $0.79
  • 50 Day Moving Average: $0.99
  • 200 Day Moving Average: $0.91
  • Trailing P/E Ratio: N/A
  • P/E Growth: -0.02
  • Market Cap: $10.91M
  • Outstanding Shares: 13,815,000
  • Beta: 2.34
Additional Links:
Companies Related to Neothetics:

Analyst Ratings

Consensus Ratings for Neothetics (NASDAQ:NEOT) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $16.00 (1,925.32% upside)

Analysts' Ratings History for Neothetics (NASDAQ:NEOT)
Show:
DateFirmActionRatingPrice TargetDetails
12/15/2015Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
12/15/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details
11/2/2015GuggenheimReiterated RatingBuy$16.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Neothetics (NASDAQ:NEOT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/11/2016Q2($0.40)($0.19)ViewN/AView Earnings Details
5/12/2016Q1($0.44)ViewN/AView Earnings Details
3/29/2016Q4($1.14)($0.69)ViewN/AView Earnings Details
11/12/2015Q315($0.84)($1.26)ViewN/AView Earnings Details
8/13/2015Q215($1.14)($0.69)ViewN/AView Earnings Details
5/14/2015Q115($0.93)($0.50)ViewN/AView Earnings Details
3/26/2015Q414($0.32)($0.45)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neothetics (NASDAQ:NEOT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Neothetics (NASDAQ:NEOT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neothetics (NASDAQ:NEOT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/30/2015Alta Partners Viii, L.P.InsiderSell797,987$1.51$1,204,960.37View SEC Filing  
12/29/2015Alta Partners Viii, L.P.Major ShareholderSell493,654$1.53$755,290.62View SEC Filing  
12/28/2015Alta Partners Viii, L.P.Major ShareholderSell54,333$1.59$86,389.47View SEC Filing  
12/17/2015Kenneth W. LockeInsiderSell598$1.26$753.48View SEC Filing  
12/17/2015Susan A. KnudsonCFOSell1,005$1.26$1,266.30View SEC Filing  
12/15/2015Alta Partners Viii, L.P.Major ShareholderSell529,261$1.44$762,135.84View SEC Filing  
11/18/2015Kenneth W. LockeinsiderSell6,098$8.30$50,613.40View SEC Filing  
9/18/2015Christopher KemmererVPSell1,000$12.20$12,200.00View SEC Filing  
9/1/2015Susan A. KnudsonCFOSell3,000$11.33$33,990.00View SEC Filing  
3/19/2015George W MahaffeyCEOBuy1,000$7.76$7,760.00View SEC Filing  
11/25/2014Daniel JanneyDirectorSell149,286$14.00$2,090,004.00View SEC Filing  
11/25/2014Rmi Investments S.A.R.L.Major ShareholderBuy70,000$14.00$980,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neothetics (NASDAQ:NEOT)
DateHeadline
News Icon301 Moved Permanently (NASDAQ:NEOT)
www.biomedreports.com - August 11 at 9:37 AM
nasdaq.com logoNeothetics Provides Business Update and Reports Second Quarter 2016 Financial Results (NASDAQ:NEOT)
www.nasdaq.com - August 11 at 9:37 AM
sg.finance.yahoo.com logoNeothetics reports 2Q loss (NASDAQ:NEOT)
sg.finance.yahoo.com - August 11 at 9:37 AM
publicnow.com logoNeothetics to Provide a Business Update and Release Second Quarter 2016 Financial Results Thursday, August 11, 2016 (NASDAQ:NEOT)
www.publicnow.com - August 4 at 9:37 AM
4-traders.com logoNEOTHETICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:NEOT)
www.4-traders.com - June 19 at 10:23 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:NEOT)
biz.yahoo.com - June 17 at 8:01 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; (NASDAQ:NEOT)
biz.yahoo.com - June 6 at 8:01 AM
News IconNeothetics, Inc. (NEOT) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:NEOT)
www.sharetrading.news - May 30 at 7:20 PM
sg.finance.yahoo.com logoNeothetics reports 1Q loss (NASDAQ:NEOT)
sg.finance.yahoo.com - May 12 at 8:13 AM
publicnow.com logoNeothetics Reports First Quarter 2016 Financial Results (NASDAQ:NEOT)
www.publicnow.com - May 12 at 8:07 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:NEOT)
biz.yahoo.com - May 12 at 8:01 AM
biz.yahoo.com logoQ1 2016 Neothetics Inc Earnings Release - Before Market Open (NASDAQ:NEOT)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoNeothetics to Release First Quarter 2016 Financial Results (NASDAQ:NEOT)
www.publicnow.com - May 5 at 8:21 AM
finance.yahoo.com logoStocks To Watch: Investors Are Considering These on Monday April 25th (NASDAQ:NEOT)
finance.yahoo.com - April 25 at 11:30 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal (NASDAQ:NEOT)
biz.yahoo.com - February 18 at 4:08 PM
finance.yahoo.com logoNeothetics Announces Leadership Change and Preliminary Update on LIPO-202 (NASDAQ:NEOT)
finance.yahoo.com - February 18 at 4:00 PM
News IconSpeaker: Combining peels with other procedures ‘safe’, easy, inexpensive (NASDAQ:NEOT)
www.healio.com - January 17 at 7:54 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:NEOT)
biz.yahoo.com - December 23 at 4:47 PM
247wallst.com logoWhy Neothetics Is Getting Destroyed (NASDAQ:NEOT)
247wallst.com - December 15 at 1:15 PM
finance.yahoo.com logoBreaking: This Biotech Just Got Blown Up on a Late Stage Trial (NASDAQ:NEOT)
finance.yahoo.com - December 14 at 5:54 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:NEOT)
biz.yahoo.com - December 14 at 5:02 PM
noodls.com logoNeothetics Reports LIPO-202 Top-Line Phase 3 Trial Results for the Reduction of Central Abdominal Bulging (NASDAQ:NEOT)
www.noodls.com - December 14 at 4:39 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:NEOT)
biz.yahoo.com - December 10 at 4:39 PM
finance.yahoo.com logoNEOTHETICS, INC. Financials (NASDAQ:NEOT)
finance.yahoo.com - December 8 at 1:17 PM
noodls.com logoNeothetics Announces Issuance by USPTO of Fourth Patent Directed to LIPO-202 Lead Clinical Asset (NASDAQ:NEOT)
www.noodls.com - December 7 at 8:24 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:NEOT)
biz.yahoo.com - December 1 at 5:21 PM
noodls.com logoNeothetics Tightens Guidance for Timing of Top-Line Pivotal Phase 3 Data (NASDAQ:NEOT)
www.noodls.com - December 1 at 7:43 AM

Social

Neothetics (NASDAQ:NEOT) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff